Muffin Top vs Visceral Fat: Key Differences

The difference between muffin top and visceral fat is more than cosmetic: one is visible, the other is hidden and far more dangerous. A muffin top refers to subcutaneous fat sitting just beneath the skin around the waist, whereas visceral fat lies deep inside the abdominal cavity, surrounding vital organs. Understanding the distinction matters because visceral fat drives insulin resistance, cardiovascular disease and metabolic syndrome, yet it cannot be seen or felt from the outside. This article explains how the two fat types differ, how UK clinicians assess them, and what you can do to reduce both safely.

What is the difference between a muffin top and visceral fat?

A muffin top is subcutaneous fat stored beneath the skin around the waist, whereas visceral fat is stored deep inside the abdominal cavity surrounding the organs. The two are anatomically distinct and carry different levels of health risk.

A muffin top is a colloquial, non-clinical term for excess subcutaneous fat stored directly beneath the skin around the waist and hips, whereas visceral fat is stored deep inside the abdominal cavity, surrounding the internal organs. The two types of fat are anatomically distinct, behave differently in the body, and carry different levels of health risk.

Subcutaneous fat is the soft, pinchable layer you can feel when you press your fingers into your abdomen or flanks. It sits between the skin and the abdominal muscle wall and is visible as the characteristic bulge over a waistband. This fat acts partly as an energy reserve and provides some insulation and cushioning.

Visceral fat, by contrast, lies behind the abdominal muscles and wraps around organs such as the liver, pancreas and intestines. Because it is hidden from view, it cannot be seen or felt from the outside. Visceral fat is metabolically active, releasing fatty acids and inflammatory signalling molecules directly into the portal circulation, which drains into the liver. This proximity to vital organs is what makes visceral fat particularly relevant to metabolic health.

It is possible to have both types simultaneously, and many people who carry a visible muffin top also have some degree of visceral fat accumulation. However, the two do not always go hand in hand, which is why body shape and weight alone are imperfect guides to internal fat distribution.

How do doctors measure visceral fat and subcutaneous fat in the UK?

Waist circumference is the most commonly used clinical proxy for visceral fat in UK practice, with NICE thresholds of 94 cm and 102 cm for men and 80 cm and 88 cm for women of European background. Lower thresholds apply to South Asian and other Asian groups.

In UK clinical practice, waist circumference is the most commonly used proxy measure for visceral fat. NICE guidance identifies thresholds above which health risk increases substantially. For men of European background, a waist circumference above 94 cm indicates increased risk and above 102 cm indicates high risk.^[1][3] For women of European background, the corresponding thresholds are 80 cm and 88 cm. Lower thresholds apply to people of South Asian and other Asian backgrounds: 90 cm for men and 80 cm for women are widely used in UK clinical practice, reflecting evidence that visceral fat accumulates at lower overall body weights in these groups.^[1][2] The evidence base for separate thresholds in people of Black African or Caribbean background is less definitive in current UK guidance, and a GP can advise on individual risk assessment.

The NHS advises measuring waist circumference at the midpoint between the bottom of the lowest rib and the top of the hip bone (iliac crest), after breathing out normally.^[3] This method is more reproducible than measuring at the umbilicus and is the approach recommended in NHS patient guidance.

Waist-to-hip ratio and waist-to-height ratio are also used in research and some clinical settings. A waist-to-height ratio above 0.5 is supported by NICE as a marker of excess central adiposity. Body mass index (BMI) is routinely recorded in NHS consultations but measures overall weight relative to height rather than fat distribution, so it does not distinguish between subcutaneous and visceral fat.

More precise imaging techniques are available but are not used routinely for fat measurement outside research or specialist settings. Dual-energy X-ray absorptiometry (DEXA) scanning can differentiate fat compartments, and magnetic resonance imaging (MRI) or computed tomography (CT) can quantify visceral fat volume directly. These are generally reserved for research studies or specialist clinical assessment rather than standard NHS primary care.

For most people, a simple tape measure applied at the correct anatomical midpoint, after a normal exhale, provides a practical and clinically meaningful estimate of central fat distribution.

Which type of body fat carries the greater health risk?

Visceral fat carries the greater health risk because it releases inflammatory cytokines and free fatty acids directly into the portal circulation, driving insulin resistance, metabolic syndrome and cardiovascular disease. Subcutaneous fat is considerably less harmful at equivalent volumes.

Visceral fat carries the greater health risk compared with subcutaneous fat, because of its metabolic activity and its anatomical proximity to the liver and other abdominal organs. Subcutaneous fat is not entirely benign, but it is considerably less harmful than visceral fat at equivalent volumes.

Visceral fat releases free fatty acids, inflammatory cytokines including interleukin-6 and tumour necrosis factor-alpha, and adipokines such as resistin, with altered adiponectin secretion.^[9][10] These substances enter the portal vein and reach the liver directly, contributing to insulin resistance, raised triglycerides, reduced HDL cholesterol and elevated blood pressure. Together, these changes form the cluster of abnormalities known as metabolic syndrome, which is associated with increased risk of type 2 diabetes, cardiovascular disease, non-alcoholic fatty liver disease and certain cancers. These associations are recognised in NICE guidance on obesity and cardiovascular risk.

Subcutaneous fat, particularly that stored in the hips, thighs and buttocks (sometimes called gluteofemoral fat), may have a degree of protective effect in some observational studies, appearing to act as a metabolic buffer that sequesters circulating lipids away from the organs.^[8] This finding is not definitive and should be interpreted cautiously. Subcutaneous abdominal fat, which contributes to the muffin top appearance, is less clearly protective and may share some metabolic characteristics with visceral fat when present in large amounts.

The practical implication is that two people with the same BMI or even the same visible waist size can have very different metabolic risk profiles depending on how much of their abdominal fat is visceral versus subcutaneous. This is why waist circumference and metabolic blood tests provide more clinically useful information than weight or BMI alone.

Can you have dangerous visceral fat without looking overweight?

Yes, it is possible to carry clinically significant visceral fat with a normal BMI, a pattern known as metabolically obese, normal weight (MONW). This is especially documented in people of South Asian and East Asian backgrounds, who accumulate visceral fat at lower body weights.

Yes, it is entirely possible to carry a clinically significant amount of visceral fat while appearing slim or having a BMI within the normal range, a pattern sometimes described in research as metabolically obese, normal weight (MONW).^[1][2] This is one of the most important reasons why body weight and appearance are unreliable guides to metabolic health.

This phenomenon is particularly well documented in people of South Asian and East Asian backgrounds, in whom visceral fat tends to accumulate at lower overall body weights and BMI values compared with people of European ancestry. This is why NICE and NHS guidance recommend lower waist circumference thresholds for South Asian and other Asian groups. The evidence for separate thresholds in people of Black African or Caribbean background is less established in current UK guidance, and individual assessment by a GP is advisable.

Sedentary behaviour, low muscle mass, a diet high in refined carbohydrates and ultra-processed foods, excess alcohol consumption, poor sleep and chronic stress have all been associated with visceral fat accumulation independent of total body weight. Someone who is lightly built but largely inactive, eats a poor diet and carries most of their fat centrally may have a worse metabolic profile than a heavier person who is physically active and carries fat peripherally.

Conversely, some people who appear to carry a prominent muffin top may have relatively modest amounts of visceral fat if most of their abdominal fat is subcutaneous. Blood tests including HbA1c (the usual first-line test for diabetes risk in UK primary care), fasting glucose where appropriate, a lipid profile and liver function tests, alongside waist circumference measurement, give a more complete picture of metabolic risk than appearance alone. If you are concerned, a GP can arrange these investigations.

What lifestyle changes help reduce both types of fat?

A sustained calorie deficit combining dietary change and physical activity is the most evidence-based approach, in line with NICE guidance. Visceral fat responds more rapidly than subcutaneous fat, so metabolic improvements can occur before visible body shape changes.

A sustained calorie deficit achieved through a combination of dietary change and increased physical activity is the most evidence-based approach to reducing both subcutaneous and visceral fat, in line with NICE guidance on the management of overweight and obesity. Visceral fat tends to respond more rapidly to lifestyle intervention than subcutaneous fat, which means metabolic improvements can occur even before visible changes in body shape become apparent.

In terms of diet, NICE guidance supports a balanced, reduced-calorie diet rather than any single prescriptive eating pattern. Reducing intake of ultra-processed foods, refined carbohydrates, added sugars and alcohol is consistent with NHS and NICE dietary advice for weight management and improved metabolic health, though the evidence specifically linking individual food categories to visceral fat reduction is largely observational. Alcohol reduction is associated with reductions in central adiposity. Some evidence supports higher-protein diets for preserving muscle mass during weight loss, which is important for maintaining metabolic rate.

Physical activity recommendations from the UK Chief Medical Officers' guidelines and NICE include:

• At least 150 minutes of moderate-intensity aerobic activity per week (such as brisk walking, cycling or swimming), or 75 minutes of vigorous-intensity activity

• Strength or resistance training on at least two days per week, which helps preserve lean muscle mass; both aerobic and resistance exercise have been shown to reduce visceral fat^[5][6]

• Reducing prolonged sitting, as sedentary time is independently associated with visceral fat accumulation even in people who meet weekly exercise targets^[15][16]

Sleep quality and stress management are increasingly recognised as relevant. Poor sleep and chronically elevated cortisol levels are associated with visceral fat deposition, so addressing these factors alongside diet and exercise is worthwhile.

For people who have not achieved sufficient benefit from lifestyle changes alone, a GP can discuss whether additional support is appropriate, including referral to a structured weight management programme or assessment for pharmacological treatment. Access to NHS structured weight management services and pharmacotherapy depends on local Integrated Care Board (ICB) commissioning arrangements and tiered eligibility criteria. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight management consultations, with prescriber review and pharmacist support, where a range of options may be considered if clinically appropriate.

When should you speak to your GP about excess body fat?

Speak to your GP if your waist circumference exceeds NICE risk thresholds, if you have symptoms suggesting metabolic complications, or if lifestyle changes over several months have not helped. Early assessment allows risk factors to be identified before they progress to established disease.

You should speak to your GP about excess body fat if your waist circumference exceeds the relevant risk thresholds, if you have symptoms or blood test results suggesting metabolic complications, or if lifestyle changes over several months have not produced meaningful improvement. Early assessment allows risk factors to be identified and managed before they progress to established disease.

Specific reasons to arrange a GP appointment include:

• Waist circumference above 102 cm in men or 88 cm in women of European background, or above 90 cm in men or 80 cm in women of South Asian or other Asian background; if you are unsure which threshold applies to you, a GP can advise

• Symptoms that may suggest metabolic complications, such as increased thirst, frequent urination, persistent fatigue, or unexplained changes in mood or energy

• A personal or family history of type 2 diabetes, cardiovascular disease or fatty liver disease, which increases the importance of monitoring fat distribution

• Difficulty losing weight despite sustained dietary and activity changes, which may warrant investigation for underlying conditions such as hypothyroidism or polycystic ovary syndrome

At a GP appointment, you can expect a discussion of your medical history, measurement of waist circumference and blood pressure, and blood tests. HbA1c is the usual first-line test for diabetes risk in UK primary care; fasting glucose may also be used where appropriate. A full lipid profile and liver function tests are also commonly requested. Depending on results, your GP may refer you to a structured NHS weight management programme, a dietitian, or a specialist service. Access to these services depends on local Integrated Care Board (ICB) arrangements and tiered eligibility criteria.

If you experience chest pain, severe breathlessness or sudden neurological symptoms at any point, call 999 immediately, as these may indicate a cardiac or vascular emergency. For urgent but non-emergency concerns outside GP hours, contact NHS 111.

Scientific References

1. Overweight and obesity management – Identifying and assessing overweight, obesity and central adiposity (NG246).
2. Overweight and obesity management – Appendix A1: Summary of evidence from surveillance (NG246).
3. Overweight and obesity in adults.
4. Calculate your waist to height ratio.
5. Overweight and obesity management – Physical activity and diet (NG246).
6. UK Chief Medical Officers' physical activity guidelines.
7. Physical activity guidelines for adults aged 19 to 64.
8. Gluteofemoral body fat as a determinant of metabolic health. Manolopoulos KN et al. International Journal of Obesity..
9. Male Obesity and Cardiometabolic Risk: Inflammatory Mechanisms and Clinical Implications. Biomedicines..
10. Immunometabolism of exercise and sedentary lifestyle. Cirugia y cirujanos..
11. Stop feeding cancer: pro-inflammatory role of visceral adiposity in liver cancer. Cytokine..
12. Lifestyle-Induced Visceral Fat Loss as a Key Target for Durable Cardiometabolic Health: MRI-Assessed 5- and 10-Year Follow-Up After 2 Clinical Trials. Circulation..
13. Effects of concurrent training on fat mass and its distribution in individuals with overweight or obesity: a systematic review, meta-analysis, and exploratory regression analysis. BMC Public Health..
14. Comparative Efficacy of Exercise Type on Visceral Adipose Tissue in Patients With Prediabetes and Type 2 Diabetes Mellitus: A Systematic Review With Pairwise and Network Meta-Analyses. Obesity Reviews..
15. Effects of sedentary behavior and daily walking steps on body mass index and body composition. Journal of Diabetes Investigation..
16. Associations of physical activity and sedentary time with body composition in Brazilian young adults. Scientific Reports..
17. Association of Television Viewing Time with Body Composition and Calcified Subclinical Atherosclerosis in Singapore Chinese. PLoS One..

Frequently Asked Questions